Drug intelligence / Profile preview

aluminum hydroxide + magnesium trisilicate

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Aluminum hydroxide + magnesium trisilicate is a combination antacid used to treat symptoms caused by excess stomach acid, such as heartburn, indigestion, sour stomach, and upset stomach. The drug works by neutralizing existing gastric acid in the stomach through the basic properties of its two components: aluminum hydroxide and magnesium trisilicate. This action provides rapid relief from symptoms but does not prevent future acid production. It is available in various oral forms including chewable tablets and liquids. The combination may also be used for other conditions as determined by a healthcare provider[1][2][3].

Brand names: Alenic AlkaFoaming AntacidGavisconGenaton
Other names: aluminum hydroxide and magnesium trisilicate

Beyond the preview

Go deeper on aluminum hydroxide + magnesium trisilicate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on aluminum hydroxide + magnesium trisilicate.

Explore the full profile